Matthew Stanton
Stock Analyst at Jefferies
(0.46)
# 3,894
Out of 4,711 analysts
5
Total ratings
33.33%
Success rate
-11.6%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $7.86 | +1.78% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $2.00 | +62.50% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $27.39 | -19.68% | 1 | Apr 4, 2024 | |
| AZTA Azenta | Initiates: Hold | $64 | $50.43 | +26.91% | 1 | Apr 4, 2024 |
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $7.86
Upside: +1.78%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $2.00
Upside: +62.50%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $27.39
Upside: -19.68%
Azenta
Apr 4, 2024
Initiates: Hold
Price Target: $64
Current: $50.43
Upside: +26.91%